Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
Xanamem Alzheimer's trial infographic: XanaMIA CDR-SB result, 247 patients, over-75 subgroup
  • Pharmaceuticals
46 minutes ago

Xanamem Alzheimer’s Trial Misses Main Goal, Actinogen Shares Plunge Over 80%

Actinogen’s oral Xanamem missed its CDR-SB primary endpoint in the 247-patient XanaMIA Alzheimer’s trial. We explain the over-75 subgroup signal, the share collapse and what comes next.

  • Merck sac-TMT Trial Wins on Survival in Late-Line Gastroesophageal Cancer, Misses on PFS
  • FloLipid Withdrawal: FDA Moves to Pull the First US Liquid Statin Over Missing Annual Reports
  • Viatris Pacira Acquisition Closes: $1.65B Buys Exparel and a Non-Opioid Pain Franchise
AI drug discovery timelines infographic with Novartis, Novo Nordisk and market data
  • Industry Insights
2 hours ago

AI Drug Discovery Timelines: Big Pharma Says Early Research Now Runs Up to Twice as Fast

Novartis, Novo, Sanofi, BMS and others say AI has cut early drug discovery time by up to half. The numbers, the frontier AI rivalry and what has not changed.

  • UnitedHealth Star Ratings Lawsuit: Insurer Sues CMS Over 45 Medicare Advantage Contracts
  • Merck Isomorphic Labs Collaboration: AI Design Deal Targets One Undisclosed Cancer Target
  • AbbVie DISCO Pharmaceuticals Deal: $2.54B Bet on AND-Gated Bispecifics for Solid Tumours
UnitedHealth star ratings lawsuit infographic showing 45 contracts and 26 disputed measures
  • Industry Insights
3 hours ago

UnitedHealth Star Ratings Lawsuit: Insurer Sues CMS Over 45 Medicare Advantage Contracts

UnitedHealth sues CMS over 2027 Medicare Advantage star ratings for 45 contracts, claiming up to 1.5 stars were lost. What is at stake and what comes next.

  • AI Drug Discovery Timelines: Big Pharma Says Early Research Now Runs Up to Twice as Fast
  • Merck Isomorphic Labs Collaboration: AI Design Deal Targets One Undisclosed Cancer Target
  • AbbVie DISCO Pharmaceuticals Deal: $2.54B Bet on AND-Gated Bispecifics for Solid Tumours
Merck sac-TMT trial infographic: TroFuse-015 overall survival win in gastroesophageal cancer
  • Pharmaceuticals
4 hours ago

Merck sac-TMT Trial Wins on Survival in Late-Line Gastroesophageal Cancer, Misses on PFS

TroFuse-015 met its overall survival goal for Merck and Kelun’s TROP2 ADC sac-TMT in 473 pretreated gastroesophageal cancer patients, but missed progression-free survival.

  • Xanamem Alzheimer’s Trial Misses Main Goal, Actinogen Shares Plunge Over 80%
  • FloLipid Withdrawal: FDA Moves to Pull the First US Liquid Statin Over Missing Annual Reports
  • Viatris Pacira Acquisition Closes: $1.65B Buys Exparel and a Non-Opioid Pain Franchise
  • Medical Devices

Smith+Nephew Says Talks With J&J Have Ended and Cuts 2026 Outlook as US Hip and Knee Sales Weaken

Megan Wood 46 minutes ago
  • Lifestyle and Wellness

Wonders of Waterless Cosmetics: Discover the New Era!

Megan Wood 46 minutes ago
Xanamem Alzheimer's trial infographic: XanaMIA CDR-SB result, 247 patients, over-75 subgroup
  • Pharmaceuticals

Xanamem Alzheimer’s Trial Misses Main Goal, Actinogen Shares Plunge Over 80%

Megan Wood46 minutes ago010 mins

Actinogen’s oral Xanamem missed its CDR-SB primary endpoint in the 247-patient XanaMIA Alzheimer’s trial. We explain the over-75 subgroup signal, the share collapse and what comes next.

Read More
AI drug discovery timelines infographic with Novartis, Novo Nordisk and market data
  • Industry Insights

AI Drug Discovery Timelines: Big Pharma Says Early Research Now Runs Up to Twice as Fast

Megan Wood2 hours ago011 mins

Novartis, Novo, Sanofi, BMS and others say AI has cut early drug discovery time by up to half. The numbers, the frontier AI rivalry and what has not changed.

Read More
UnitedHealth star ratings lawsuit infographic showing 45 contracts and 26 disputed measures
  • Industry Insights

UnitedHealth Star Ratings Lawsuit: Insurer Sues CMS Over 45 Medicare Advantage Contracts

Megan Wood3 hours ago09 mins

UnitedHealth sues CMS over 2027 Medicare Advantage star ratings for 45 contracts, claiming up to 1.5 stars were lost. What is at stake and what comes next.

Read More
Merck sac-TMT trial infographic: TroFuse-015 overall survival win in gastroesophageal cancer
  • Pharmaceuticals

Merck sac-TMT Trial Wins on Survival in Late-Line Gastroesophageal Cancer, Misses on PFS

Megan Wood4 hours ago09 mins

TroFuse-015 met its overall survival goal for Merck and Kelun’s TROP2 ADC sac-TMT in 473 pretreated gastroesophageal cancer patients, but missed progression-free survival.

Read More
Merck Isomorphic Labs collaboration infographic on AI drug discovery for oncology
  • Industry Insights

Merck Isomorphic Labs Collaboration: AI Design Deal Targets One Undisclosed Cancer Target

Megan Wood10 hours ago09 mins

Merck taps Isomorphic Labs to design small molecules against one strategic cancer target. Deal terms, the co-funding twist and what it means for AI drug discovery.

Read More
AbbVie DISCO Pharmaceuticals deal infographic showing upfront and milestone payments
  • Industry Insights

AbbVie DISCO Pharmaceuticals Deal: $2.54B Bet on AND-Gated Bispecifics for Solid Tumours

Megan Wood13 hours ago010 mins

AbbVie pays DISCO Pharmaceuticals $40M upfront, with up to $2.5B in milestones, for options on AND-gated bispecific cancer drugs built from surfaceome mapping.

Read More
Sanofi Insmed acquisition infographic with Insmed market value and Brinsupri sales
  • Industry Insights

Sanofi Insmed Acquisition Talk: What a Bid for the Brinsupri Maker Would Mean

Megan Wood14 hours ago09 mins

Sanofi is weighing a takeover of Insmed, maker of bronchiectasis drug Brinsupri, Bloomberg reported. Insmed rose about 16% from a $26.3B value. Here is what is known.

Read More
Novartis sales growth guidance infographic: 5% CAGR to 2031, Kesimpta $8bn peak, 40% margin by 2029
  • Industry Insights

Novartis Sales Growth Guidance: 5% a Year to 2031 as Kesimpta Peak Rises to $8B

Megan Wood1 day ago09 mins

Novartis guides to 5% annual sales growth through 2031, down from 5-6%, while raising peak sales for Kesimpta, Scemblix and Leqvio.

Read More
FloLipid withdrawal FDA liquid statin infographic
  • Pharmaceuticals

FloLipid Withdrawal: FDA Moves to Pull the First US Liquid Statin Over Missing Annual Reports

Megan Wood1 day ago1 day ago010 mins

FDA has proposed withdrawing approval of Salerno Pharmaceuticals’ FloLipid simvastatin suspension after repeated missing annual reports. Hearing deadline 18 December.

Read More
  • 1
  • 2
  • 3
  • …
  • 63

Categories

  • Healthcare IT (26)
  • Industry Insights (367)
  • Lifestyle and Wellness (24)
  • Medical Devices (45)
  • Pharmaceuticals (113)
  • Uncategorized (1)

Recent Posts

  • Xanamem Alzheimer’s Trial Misses Main Goal, Actinogen Shares Plunge Over 80%
  • AI Drug Discovery Timelines: Big Pharma Says Early Research Now Runs Up to Twice as Fast
  • UnitedHealth Star Ratings Lawsuit: Insurer Sues CMS Over 45 Medicare Advantage Contracts
  • Merck sac-TMT Trial Wins on Survival in Late-Line Gastroesophageal Cancer, Misses on PFS
  • Merck Isomorphic Labs Collaboration: AI Design Deal Targets One Undisclosed Cancer Target

You May Have Missed

Cardiac Arrhythmia Monitoring Devices Market Revenue, Trends, and Strategic Insights by 2030
  • Industry Insights

Cardiac Arrhythmia Monitoring Devices Market Revenue, Trends, and Strategic Insights by 2030

Megan Wood 6 months ago
Mylan telmisartan amlodipine recall graphic about generic drug quality control
  • Pharmaceuticals

Mylan Telmisartan Amlodipine Recall: Quality-Control Lessons for the Generics Industry

Megan Wood 3 weeks ago
Connected Medical Devices Market Revenue, Trends, and Strategic Insights by 2030
  • Industry Insights

Connected Medical Devices Market Revenue, Trends, and Strategic Insights by 2030

Megan Wood 6 months ago
AI in Healthcare Market Revenue, Trends, and Strategic Insights by 2035
  • Industry Insights

AI in Healthcare Market Revenue, Trends, and Strategic Insights by 2035

Megan Wood 5 months ago5 months ago
India pharmaceutical market growth 2026 graphic about company winners
  • Industry Insights

India Pharmaceutical Market Growth 2026: Who Is Capturing the 12% Rise to ₹70,180 Crore

Megan Wood 3 weeks ago3 weeks ago
Fetal Monitoring Market
  • Industry Insights

Fetal Monitoring Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 9 months ago9 months ago
Antibody Production Market
  • Industry Insights

Antibody Production Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 8 months ago
Bristol Myers Squibb Q3 2026 results graphic about growth versus legacy portfolio
  • Industry Insights

Bristol Myers Squibb Q3 2026 Results: Growth Portfolio Now 59% of Sales as Eliquis Cliff Nears

Megan Wood 3 weeks ago
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.